Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 326 to 350 of 2003

TitleReference numberPublishedLast updated
Mirikizumab for treating moderately to severely active ulcerative colitisTA925
Baricitinib for treating severe alopecia areataTA926
Tabelecleucel for treating post-transplant lymphoproliferative disorder caused by the Epstein-Barr virus (terminated appraisal)TA923
Percutaneous deep venous arterialisation for chronic limb-threatening ischaemiaIPG773
Stroke rehabilitation in adultsNG236
Rimegepant for treating migraineTA919
Tofacitinib for treating active ankylosing spondylitisTA920
Ruxolitinib for treating polycythaemia veraTA921
Daridorexant for treating long-term insomniaTA922
Glofitamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatmentsTA927
Virtual ward platform technologies for acute respiratory infections: early value assessmentHTE13
Thyroid disease: assessment and managementNG145
Bimekizumab for treating axial spondyloarthritisTA918
Pegunigalsidase alfa for treating Fabry diseaseTA915
Bimekizumab for treating active psoriatic arthritisTA916
Ovarian cancer: recognition and initial managementCG122
Urinary incontinence in neurological disease: assessment and managementCG148
Suspected neurological conditions: recognition and referralNG127
Hearing loss in adults: assessment and managementNG98
COVID-19 rapid guideline: haematopoietic stem cell transplantationNG164
Artificial intelligence (AI) technologies to aid contouring for radiotherapy treatment planning: early value assessmentHTE11
KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medication: early value assessmentHTE10
Removal, preservation and reimplantation of ovarian tissue for restoring fertility after gonadotoxic treatmentIPG772
Birch bark extract for treating epidermolysis bullosaHST28
Pembrolizumab for previously treated endometrial, biliary, colorectal, gastric or small intestine cancer with high microsatellite instability or mismatch repair deficiencyTA914

Results per page

  1. 10
  2. 25
  3. 50
  4. All